Several new systematic reviews and meta-analyses on EMDR therapy were published in 2025, and together they point in the same direction: EMDR reduces post-traumatic stress symptoms compared with waitlists and usual care, and performs about as well as other established trauma-focused therapies. The same reviews are unusually blunt about the limits of that evidence, with most rating the certainty of the pooled findings as low or very low.
This is a plain summary of what landed in 2025 and what it means in practice, for therapists and for people using bilateral stimulation at home. Every study cited is linked so you can read the source yourself.
Important distinction: the research below studies EMDR therapy delivered by trained clinicians. Bilateral stimulation devices such as tappers are tools used inside that therapy and in self-guided calming routines. A device is not a treatment and does not replace therapy.
What did the 2025 EMDR reviews conclude?
The headline conclusion across the 2025 literature is consistency, not novelty. EMDR continues to outperform inactive comparison conditions such as waitlist and usual care, and it continues to look broadly comparable to other psychological therapies for post-traumatic stress.
What changed in 2025 is the tone. Reviewers spent more space on methodological quality, small sample sizes, and the risk that waitlist comparisons inflate effect estimates. That is worth understanding before quoting any single number.
Finding 1: large effects versus waitlist in adults, with wide uncertainty
A systematic review and meta-analysis published in the British Journal of Psychology in 2025 by Simpson and colleagues screened more than 2,000 records and identified 16 randomised controlled trials providing up to date data on EMDR for post-traumatic stress in adults. For treatment delivered more than three months after the index event, EMDR was statistically better than waitlist or usual care on self-reported symptom scales.
The pooled effect was large: a standardised mean difference of 1.86 post-treatment, with a 95 percent credible interval of 1.18 to 2.58, and 2.44 at three-month follow-up, with a credible interval of 0.91 to 3.93. Note how wide those intervals are. The direction is clear, the precise size is not.
EMDR was statistically significantly better than waitlist or usual care in reducing PTSD symptoms, as measured with self-report scales, both post-treatment and at three-month follow-up.
Simpson et al., British Journal of Psychology, 2025
Finding 2: an overview of reviews says the certainty is low
An overview of systematic reviews with meta-analysis published in the Journal of Affective Disorders in August 2025 pooled the existing review-level evidence rather than individual trials. It reported that EMDR may increase the likelihood of losing a PTSD diagnosis at post-treatment, with a risk ratio of 2.13 and a 95 percent confidence interval of 1.08 to 4.23.
The authors then added the caveat that matters most: the certainty of evidence across most of the included meta-analyses was low or very low, and the results should be interpreted with caution. In their summary, EMDR reduces symptoms especially against inactive controls, and shows similar effectiveness to other psychological therapies.
Finding 3: the child and adolescent evidence base is real but thin
A companion systematic review and meta-analysis published in late 2025 looked specifically at children and adolescents. From 1,220 unique records, only nine studies met inclusion criteria, with eight randomised controlled trials covering 794 participants providing clinical effectiveness data.
The conclusion was positive and cautious in equal measure: EMDR was effective in reducing post-traumatic stress symptoms in young people, particularly compared with waitlist or usual care, but the evidence base is limited and more high quality trials are needed. Separately, a 2025 study of group EMDR with adolescents affected by an earthquake reported reductions in trauma, depression and anxiety symptoms alongside real implementation challenges in disaster settings.
Finding 4: cost-effectiveness entered the conversation
One quiet shift in 2025 is that reviewers started asking about value, not just efficacy. The Simpson review included cost-effectiveness as a formal outcome, measured in quality-adjusted life years, and identified one modelling-based study that found EMDR to be the most cost-effective option among the eleven interventions compared, including trauma-focused cognitive behavioural therapy.
That is a single modelling study, so read it as an early signal rather than a settled conclusion. Still, for clinicians negotiating with funders or insurers, cost data is often what moves a decision, and the child and adolescent review explicitly called for within-trial cost analyses in future research.
Finding 5: the mechanism debate is still open
None of the 2025 outcome reviews settle why bilateral stimulation contributes to EMDR. The dominant explanation remains the working memory account: holding a distressing image in mind while performing a second attention-demanding task leaves less capacity for vivid recall, and the memory is reported as less vivid and less emotionally charged afterwards.
More recent work complicates that picture. A 2024 study in Cerebral Cortex argued that bilateral eye movements may facilitate concurrent perception and memory processing rather than simply competing for resources. Earlier laboratory work comparing modalities found eye movements more taxing on working memory than tones in some paradigms, which is one reason tactile, visual and auditory stimulation are not perfectly interchangeable. We unpacked that comparison in our article on stimulation modalities.
The 2025 reviews at a glance
| Review | Population | Main finding | Main caveat |
|---|---|---|---|
| Simpson et al., British Journal of Psychology, 2025 | Adults, 16 RCTs | Large symptom reduction versus waitlist or usual care, sustained at 3 months | Wide credible intervals, self-report outcomes |
| Overview of reviews, Journal of Affective Disorders, Aug 2025 | Adults, review level | Higher likelihood of losing PTSD diagnosis, similar to other therapies | Certainty of evidence mostly low or very low |
| Children and adolescents review, 2025 | 8 RCTs, 794 participants | Effective versus waitlist or usual care in young people | Only nine eligible studies from 1,220 records |
| Cost-effectiveness modelling, included in Simpson 2025 | Adults | Most cost-effective of 11 compared interventions | Single modelling study, not trial-based |
What this means if you use tappers at home
The 2025 evidence is about structured therapy, not about self-guided device use, so it cannot be transferred directly to a home routine. What it does support is the underlying idea that rhythmic alternating attention is a legitimate object of serious clinical study rather than a gimmick.
In practice, most people using tappers at home use them for grounding routines: a few slow minutes before sleep, during a breathing exercise, or while journaling. Many users report feeling calmer and more settled during these routines. That is a reasonable expectation to hold. Expecting a device to process trauma on its own is not, and any brand suggesting otherwise is overstepping what the research supports. Our article on using tappers without a therapist goes through this boundary in detail.
What this means for EMDR therapists
Three practical implications stand out for clinicians. First, the direction of the evidence continues to support EMDR as a first-line trauma-focused option, which matters for referrals and for conversations with sceptical colleagues. Second, the certainty caveats are worth quoting honestly rather than hiding, because clients increasingly arrive having read the same reviews through an AI assistant.
Third, the cost-effectiveness signal is a new argument for practices seeking funding or insurer recognition. If you are equipping a practice, our guide to choosing devices for clinical use covers the equipment side, including hygiene between clients and what to look for in a shared-use device.
Where devices fit into this picture
Devices do not change what the research says. They change the friction of applying it. In session, a therapist needs stimulation that is reliable, quiet, adjustable and quick to clean. Between sessions, a client needs something simple enough to reach for without thinking about it.
The market splits roughly into wired clinical kits, which are durable and inexpensive but tethered, and wireless app-controlled devices, which cost more and add configurability. TouchPoints, TheraTapper, NeuroTek, Bi-Tapp, Wevana and EMDR Kit each occupy a slightly different point on that line, and several of them are well built. The honest summary is that no device on this market has its own outcome trial behind it.
Where ALMA sits. Our app-controlled tappers are inspired by EMDR practice and built for both clinical and home use at $139, below most wireless alternatives on this market.
- Food-grade silicone shell that is soft and reassuring in the hand, with a palm-sized shape that is easy to hold through a long set
- App control over intensity, speed, light and duration, so settings can be matched to the client rather than to the hardware
- IPX7 water resistance, which is rare in this category and makes wiping down between clients straightforward
- USB-C charging and 3 hours or more of battery, enough for a full clinic day
- Quiet operation, sessions run from the app
- Coming soon on our roadmap: a video session feature allowing a therapist to control a client's tappers remotely
Frequently asked questions
Is EMDR still considered evidence-based in 2026?
Yes. The 2025 reviews continue to find that EMDR reduces post-traumatic stress symptoms compared with waitlist and usual care, and performs similarly to other psychological therapies. Reviewers also note that the certainty of much of the pooled evidence is low, which is a call for better trials rather than a reversal.
Do these studies prove that tappers work?
No. These reviews study EMDR therapy as a whole protocol, not individual stimulation devices. Tactile devices are one way of delivering the bilateral component within that protocol, and no consumer tapper on the market has its own outcome trial.
Does the research say tactile stimulation is better than eye movements?
Not clearly. Laboratory work suggests different modalities tax working memory to different degrees, with eye movements outperforming tones in some paradigms, while clinical protocols routinely use all three. Tactile stimulation is often chosen for practical reasons, including telehealth, eye strain and client preference.
Where can I follow new EMDR research myself?
The EMDR International Association maintains a recent research page that tracks new publications, and most of the reviews cited here are open access on PubMed Central.
Sources
- Simpson et al., Clinical and cost-effectiveness of EMDR for treatment and prevention of PTSD in adults, British Journal of Psychology, 2025
- Effects of EMDR vs. waiting list for adults with post-traumatic stress disorder, Journal of Affective Disorders, August 2025
- Clinical and cost-effectiveness of EMDR for PTSD in children and adolescents, systematic review and meta-analysis, 2025
- Group EMDR therapy for disaster-affected adolescents, 2025
- Eye movement intervention facilitates concurrent perception and memory processing, Cerebral Cortex, 2024
- Eye movements superior to beeps in taxing working memory and reducing vividness of recollections, Behaviour Research and Therapy
ALMA tappers are wellness devices inspired by EMDR practice. They are not medical devices, they do not diagnose or treat any condition, and they are not a substitute for care from a qualified professional. If you are working through trauma, please do so with a trained therapist.